CTRI/2012/12/003180招募中1 期
Safety and efficacy of oral valproate in recurrent or progressive brain tumors - NA
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age 5-65yrs
- •2) KPS/Lansky 50
- •3) Adequate Organ function ( CBC,RFT and LFT)
- •4) Life expectancy of around 6 Months
- •5) At least 4 weeks from last chemo therapy or radio therapy
- •6)No other concurrent anti epileptic agents except valproate ( patients receiving valproate before enrolling in study should have total through VA concentration 100�g/mL
- •within past 2 weeks)
- •7) Signed study specific consent form from patients if (adults) and guardians or legally accepted Representatives (If children) Assent from children
排除标准
- •1)Pregnancy or lactating
- •2)Uncontrolled infection
- •3)Expected poor compliance
- •4)Organ dysfunction or metabolic disorder
- •5)Concurrent radiotherapy, biologic therapy or immunotherapy
研究者
相似试验
已完成
不适用
Aripiprazole effect in the treatment of maniaBipolar Disorder type I.Bipolar affective disorderIRCT201510222166N2niversity of Social Welfare and Rehabilitation Sciences40
已完成
2 期
Efficacy and safety of valproic acid in patients with postviral olfactory dysfunctiopostviral olfactory dysfunctionJPRN-UMIN000019966Shiga university of Medical Science15
已完成
2 期
Study of a new medicine combination in ovarian cancer which has come back after initial therapyCTRI/2020/01/022781JIPMER27
招募中
不适用
comparing 2 tablets for treating fits in childreCTRI/2019/04/018520JIPMER
尚未招募
2 期
Comparison of efficacy of Sodium Valproate versus Levetiracetam in Status EpilepticusCTRI/2022/02/040689AIIMS PATNA